Lifecore Biomedical, Inc. \De\ (LFCR) Operating Leases (2019 - 2025)
Historic Operating Leases for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 9 years, with Q1 2025 value amounting to $5.4 million.
- Lifecore Biomedical, Inc. \De\'s Operating Leases rose 617.14% to $5.4 million in Q1 2025 from the same period last year, while for Feb 2025 it was $5.4 million, marking a year-over-year increase of 617.14%. This contributed to the annual value of $1.7 million for FY2024, which is 8219.18% down from last year.
- Lifecore Biomedical, Inc. \De\'s Operating Leases amounted to $5.4 million in Q1 2025, which was up 617.14% from $7.4 million recorded in Q4 2024.
- In the past 5 years, Lifecore Biomedical, Inc. \De\'s Operating Leases ranged from a high of $17.9 million in Q1 2021 and a low of $1.7 million during Q2 2024
- Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Operating Leases value was $7.8 million (recorded in 2022), while the average stood at $8.9 million.
- Its Operating Leases has fluctuated over the past 5 years, first soared by 3296.3% in 2023, then crashed by 8219.18% in 2024.
- Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Operating Leases (Quarter) stood at $11.3 million in 2021, then crashed by 38.12% to $7.0 million in 2022, then surged by 32.96% to $9.3 million in 2023, then decreased by 20.47% to $7.4 million in 2024, then fell by 27.23% to $5.4 million in 2025.
- Its Operating Leases was $5.4 million in Q1 2025, compared to $7.4 million in Q4 2024 and $4.8 million in Q3 2024.